Nathalie Labarrière

3.7k total citations
75 papers, 2.4k citations indexed

About

Nathalie Labarrière is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Nathalie Labarrière has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 37 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Nathalie Labarrière's work include Immunotherapy and Immune Responses (52 papers), CAR-T cell therapy research (29 papers) and Immune Cell Function and Interaction (25 papers). Nathalie Labarrière is often cited by papers focused on Immunotherapy and Immune Responses (52 papers), CAR-T cell therapy research (29 papers) and Immune Cell Function and Interaction (25 papers). Nathalie Labarrière collaborates with scholars based in France, United States and Canada. Nathalie Labarrière's co-authors include Francine Jotereau, Sylvain Simon, Brigitte Dréno, Virginie Vignard, Amir Khammari, François Lang, Marie‐Christine Pandolfino, Agnès Moreau‐Aubry, Nadine Gervois and Elisabeth Viles and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Nathalie Labarrière

75 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathalie Labarrière France	29	1.6k	1.1k	970	237	216	75	2.4k
Erik Hooijberg Netherlands	34	2.0k 1.2×	1.4k 1.2×	1.1k 1.1×	348 1.5×	176 0.8×	95	3.2k
Petra Keikavoussi Germany	15	2.4k 1.5×	1.2k 1.1×	1.3k 1.4×	157 0.7×	89 0.4×	18	2.9k
Susana Inogés Spain	28	1.8k 1.2×	1.2k 1.1×	912 0.9×	112 0.5×	163 0.8×	65	3.0k
Juan Dubrot Spain	25	1.4k 0.9×	841 0.7×	525 0.5×	153 0.6×	100 0.5×	45	2.1k
Ian A. Parish Australia	24	3.0k 1.9×	1.0k 0.9×	1.0k 1.0×	238 1.0×	194 0.9×	37	3.9k
Maria-Luisa Alegre United States	19	2.2k 1.4×	878 0.8×	929 1.0×	207 0.9×	290 1.3×	21	3.0k
Maria Ferrantini Italy	27	1.7k 1.1×	902 0.8×	768 0.8×	295 1.2×	216 1.0×	47	2.5k
Dori A. Thomas United States	9	1.2k 0.7×	885 0.8×	787 0.8×	100 0.4×	192 0.9×	9	2.0k
Patricia J. Noel United States	12	2.1k 1.3×	637 0.6×	428 0.4×	204 0.9×	162 0.8×	14	2.5k
Alla Berezovskaya United States	20	1.3k 0.8×	728 0.6×	1.2k 1.2×	171 0.7×	221 1.0×	38	2.6k

Countries citing papers authored by Nathalie Labarrière

Since Specialization

Citations

This map shows the geographic impact of Nathalie Labarrière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Labarrière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Labarrière more than expected).

Fields of papers citing papers by Nathalie Labarrière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Labarrière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Labarrière. The network helps show where Nathalie Labarrière may publish in the future.

Co-authorship network of co-authors of Nathalie Labarrière

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Labarrière. A scholar is included among the top collaborators of Nathalie Labarrière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Labarrière. Nathalie Labarrière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Fresquet, Judith, Emmanuelle Com, Charles Pineau, et al.. (2024). Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity. SHILAP Revista de lepidopterología. 32(4). 200887–200887. 8 indexed citations

2.

Boisgerault, Nicolas, et al.. (2022). The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. Frontiers in Immunology. 13. 925241–925241. 2 indexed citations

3.

Charpentier, Maud, Mike Maillasson, Emmanuelle Com, et al.. (2021). hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote MELOE‐1 translation in stressed melanoma cells. Molecular Oncology. 16(3). 594–606. 15 indexed citations

4.

Dréno, Brigitte, Amir Khammari, Virginie Vignard, et al.. (2021). Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. Cancer Immunology Immunotherapy. 70(10). 3015–3030. 11 indexed citations

5.

Manry, Jérémy, Alexandre Alcaïs, Martine Fanton d’Andon, et al.. (2020). Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology. PLoS Pathogens. 16(12). e1009107–e1009107. 28 indexed citations

6.

Khammari, Amir, Jean‐Michel Nguyen, M.‐T. Leccia, et al.. (2020). Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial. Cancer Immunology Immunotherapy. 69(8). 1663–1672. 13 indexed citations

7.

Vignard, Virginie, Nadège Marec, Gwennan André‐Grégoire, et al.. (2019). MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma. Cancer Immunology Research. 8(2). 255–267. 121 indexed citations

8.

Kervarrec, Thibault, M. Samimi, Houssem Benlalam, et al.. (2018). Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity. Cancer Immunology Immunotherapy. 67(8). 1209–1219. 8 indexed citations

9.

Simon, Sylvain, Virginie Vignard, Émilie Varey, et al.. (2017). Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy. Cancer Research. 77(24). 7083–7093. 17 indexed citations

10.

Parrot, Tiphaine, Mathilde Allard, Romain Oger, et al.. (2016). IL‐9 promotes the survival and function of human melanoma‐infiltrating CD4⁺CD8⁺ double‐positive T cells. European Journal of Immunology. 46(7). 1770–1782. 27 indexed citations

11.

Dréno, Brigitte, Amir Khammari, Anne Chantal Knol, & Nathalie Labarrière. (2014). Mélanome — Thérapeutique immunitaire : l’immunothérapie cellulaire et vaccinale. Bulletin de l Académie Nationale de Médecine. 198(2). 309–319. 1 indexed citations

12.

Vignard, Virginie, et al.. (2013). Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation. PLoS ONE. 8(9). e75421–e75421. 7 indexed citations

13.

Khammari, Amir, Nathalie Labarrière, Virginie Vignard, et al.. (2009). Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones. Journal of Investigative Dermatology. 129(12). 2835–2842. 58 indexed citations

14.

Benlalam, Houssem, Virginie Vignard, Amir Khammari, et al.. (2006). Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients. Cancer Immunology Immunotherapy. 56(4). 515–526. 33 indexed citations

15.

Vignard, Virginie, Brigitte Lemercier, Apiradee Lim, et al.. (2005). Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells. The Journal of Immunology. 175(7). 4797–4805. 77 indexed citations

16.

Benlalam, Houssem, Boris Linard, Agnès Moreau‐Aubry, et al.. (2003). Identification of Five New HLA-B*3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes. The Journal of Immunology. 171(11). 6283–6289. 44 indexed citations

17.

Linard, Boris, Stéphane Bezieau, Houssem Benlalam, et al.. (2002). A ras- Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion. The Journal of Immunology. 168(9). 4802–4808. 64 indexed citations

18.

Dréan, Eric Le, Nathalie Labarrière, Jean‐François Fonteneau, et al.. (1998). LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal. European Journal of Immunology. 28(4). 1322–1331. 1 indexed citations

19.

Dréan, Eric Le, Nathalie Labarrière, Jean‐François Fonteneau, et al.. (1998). LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal. European Journal of Immunology. 28(4). 1322–1331. 34 indexed citations

20.

Labarrière, Nathalie, Jean‐Pierre Piau, Marc G. Denis, et al.. (1994). H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells.. PubMed. 54(23). 6275–81. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact